Concepedia

Huiyuan Bai

HB

Statistics

Publications

14

Citations

533

H-Index

12

Active since

2014

Affiliations

Southwest University(Current)

Southeast University

State Key Laboratory of Digital Medical Engineering

Pennsylvania State University

National Center for Nanoscience and Technology

Huiyuan Bai is an author at Southwest University specializing in oncology, nanomedicine, and pharmacy.

Publications per year

2014–2023

14

Publications

14

MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by targeting HMGA2

Pu Zhang, Huiyuan Bai, Gentao Liu et al. · Toxicology Letters · 2015 · 89 citations

Life Sciences, Molecular Biology, Oncology +17

Prussian Blue Nanozymes Prevent Anthracycline-Induced Liver Injury by Attenuating Oxidative Stress and Regulating Inflammation

Huiyuan Bai, Fei Kong, Kaizheng Feng et al. · ACS Applied Materials & Interfaces · 2021 · 81 citations

Life Sciences, Pharmacology, Toxicology +17

Fe3O4@Pt nanozymes combining with CXCR4 antagonists to synergistically treat acute myeloid leukemia

Fei Kong, Huiyuan Bai, Ming Ma et al. · Nano Today · 2021 · 76 citations

Medicine, Oncology, Pharmacology +14

Treatment of acetaminophen-induced liver injury with exogenous mitochondria in mice

Xianxun Shi, Huiyuan Bai, Ming Zhao et al. · Translational research · 2018 · 70 citations

Veterinary Medicine, Pharmacology, Toxicology +14

CXCR4 and CD44 dual-targeted Prussian blue nanosystem with daunorubicin loaded for acute myeloid leukemia therapy

Huiyuan Bai, Tao Wang, Fei Kong et al. · Chemical Engineering Journal · 2020 · 36 citations

Pharmacy, Oncology, Pharmacology +14

1–5 of 14